Education
About Us
Working with TipRanks
Follow Us
Vincent Medical Holdings Limited (HK:1612)
:1612
1612 Stock Chart & Stats
HK$0.83
<HK$0.01(1.28%)
At close: 4:00 PM EST
HK$0.83
<HK$0.01(1.28%)
Day’s Range― - ―
52-Week RangeHK$0.36 - HK$1.32
Previous CloseN/A
Volume194.00K
Average Volume (3M)785.93K
Market Cap
HK$672.45M
Enterprise ValueHK$627.21M
Total Cash (Recent Filing)HK$204.33M
Total Debt (Recent Filing)HK$162.80M
Price to Earnings (P/E)7.5
Beta0.64
Next Earnings
Mar 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.94%
Share Statistics
EPS (TTM)0.08
Shares Outstanding659,265,800
10 Day Avg. Volume481,400
30 Day Avg. Volume785,933
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)0.44
Price to Sales (P/S)0.32
P/FCF Ratio-9.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Market DemandConsistent double-digit revenue growth in 2024 reflects sustained demand for its respiratory and critical-care devices and validates its commercial reach. Durable growth supports capacity to invest in R&D, expand distribution, and scale production over the next several quarters.
Conservative Capital StructureA strong equity base and low leverage give the company financial flexibility to fund product development, absorb cyclical pressures, and pursue strategic partnerships without high interest burden, preserving resilience across a multi-quarter horizon.
Healthy Gross And EBITDA MarginsSizable gross margin and positive EBITDA margin point to effective product pricing and manufacturing efficiency in core device lines. Sustained margins support reinvestment into R&D and distribution, underpinning longer-term competitive positioning.
Bears Say
Weak Cash Flow ConversionA collapse of free cash flow and zero OCF-to-net-income conversion in 2024 signals difficulty turning accounting profits into cash. This undermines the firm’s ability to self-fund capex, R&D, dividends, or M&A without relying on external financing over coming quarters.
Earnings VolatilityMaterial swings in EBIT and net income reduce predictability of profits and cash generation. For investors and management, volatility complicates capacity planning, budgeting, and long-term investment decisions, elevating execution risk over a 2–6 month horizon.
Relatively Low Net MarginA single-digit net margin limits the buffer to absorb commodity, supply-chain or pricing shocks and constrains internal funding for growth initiatives. Over time, this can reduce free cash flow resilience and the ability to scale without margin improvement.
Vincent Medical Holdings Limited News
1612 FAQ
What was Vincent Medical Holdings Limited’s price range in the past 12 months?
Vincent Medical Holdings Limited lowest stock price was HK$0.35 and its highest was HK$1.32 in the past 12 months.
What is Vincent Medical Holdings Limited’s market cap?
Vincent Medical Holdings Limited’s market cap is HK$672.45M.
When is Vincent Medical Holdings Limited’s upcoming earnings report date?
Vincent Medical Holdings Limited’s upcoming earnings report date is Mar 25, 2026 which is in 30 days.
How were Vincent Medical Holdings Limited’s earnings last quarter?
Vincent Medical Holdings Limited released its earnings results on Aug 20, 2025. The company reported HK$0.08 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.08.
Is Vincent Medical Holdings Limited overvalued?
According to Wall Street analysts Vincent Medical Holdings Limited’s price is currently Overvalued.
Does Vincent Medical Holdings Limited pay dividends?
Vincent Medical Holdings Limited pays a Quarterly dividend of HK$0.024 which represents an annual dividend yield of 4.94%. See more information on Vincent Medical Holdings Limited dividends here
What is Vincent Medical Holdings Limited’s EPS estimate?
Vincent Medical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vincent Medical Holdings Limited have?
Vincent Medical Holdings Limited has 659,265,800 shares outstanding.
What happened to Vincent Medical Holdings Limited’s price movement after its last earnings report?
Vincent Medical Holdings Limited reported an EPS of HK$0.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.422%.
Which hedge fund is a major shareholder of Vincent Medical Holdings Limited?
Currently, no hedge funds are holding shares in HK:1612
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vincent Medical Holdings Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
116.00%
12-Months-Change
Fundamentals
Return on Equity
14.73%
Trailing 12-Months
Asset Growth
35.25%
Trailing 12-Months
Company Description
Vincent Medical Holdings Limited
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, and anesthesia systems. The company's orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People's Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.
Technical Analysis
Suzhou Basecare Medical Corp. Ltd. Class H
―
Broncus Holding Corp.
―
Yestar Healthcare Holdings Co Ltd
―
Venus Medtech (Hangzhou), Inc. Class H
―
Austar Lifesciences Ltd.
―